Trial intelligence / Profile preview

Medtronic Pump and Codman Catheter for HAI Chemotherapy in Colorectal Carcinoma or Cholangiocarcinoma

NCT03693807Phase 2Completed

Sponsor
Memorial Sloan Kettering Cancer Center
Start
Oct 2018
Primary completion
Jun 2024
Countries
1
01

Overview

Phase 2, open-label, single-arm trial in colorectal cancer (CRC) and cholangiocarcinoma (CCA), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoints: Number of Patients Requiring Stent Replacements at 1 year and Number of Participants With Any Grade Liver Toxicity at 1 year. Started Oct 2018; status: completed.

02

Conditions

colorectal cancer (CRC)cholangiocarcinoma (CCA)

Beyond the preview

Go deeper on NCT03693807.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03693807.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call